Clinical Trial Update: Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic Steatohepatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Helicobacter pylori eradication in non-diabetic non-alcoholic fatty liver disease (NASH) has completed and posted results in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Non-alcoholic Fatty Liver Disease | Phase 2 | Status: COMPLETED | Results posted: 2012-12-21